# GIP Receptor Antagonist Studies in Humans

> **NCT02747472** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Glucose Metabolism

## Interventions

- **DRUG:** GIP-A
- **DRUG:** GIP(1-42)
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT02747472
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747472, "GIP Receptor Antagonist Studies in Humans". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02747472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*